HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rosario González-Muñiz Selected Research

Cognition Disorders

1/2021Natural Polyhydroxy Flavonoids, Curcuminoids, and Synthetic Curcumin Analogs as α7 nAChRs Positive Allosteric Modulators.
10/2014Chalcones as positive allosteric modulators of α7 nicotinic acetylcholine receptors: a new target for a privileged structure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rosario González-Muñiz Research Topics

Disease

8Pain (Aches)
02/2022 - 04/2006
4Neoplasms (Cancer)
02/2021 - 10/2011
4Inflammation (Inflammations)
01/2021 - 10/2014
3Pathologic Processes
01/2018 - 01/2007
2Peripheral Nervous System Diseases (PNS Diseases)
02/2022 - 01/2020
2Neuralgia (Stump Neuralgia)
02/2021 - 01/2007
2Cognition Disorders
01/2021 - 10/2014
2Schizophrenia (Dementia Praecox)
01/2021 - 10/2014
1Cardiovascular Diseases (Cardiovascular Disease)
08/2020
1Hyperalgesia
01/2020
1Neuroblastoma
01/2019
1Substance-Related Disorders (Drug Abuse)
12/2018
1Erythropoietic Porphyria (Congenital Erythropoietic Porphyria)
01/2018
1Hypertension (High Blood Pressure)
01/2017
1Heart Failure
01/2017
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2017
1Parkinson Disease (Parkinson's Disease)
05/2013

Drug/Important Bio-Agent (IBA)

4Analgesics (Analgesic Drugs)IBA
10/2021 - 04/2006
4Pharmaceutical PreparationsIBA
12/2018 - 05/2014
4Proteins (Proteins, Gene)FDA Link
12/2018 - 01/2007
3Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2021 - 01/2018
3Biological ProductsIBA
08/2020 - 04/2006
3Peptides (Polypeptides)IBA
12/2018 - 01/2007
2Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2022 - 01/2020
2LactamsIBA
02/2022 - 10/2011
2Ion Channels (Ion Channel)IBA
02/2021 - 01/2018
2Ligand-Gated Ion ChannelsIBA
01/2021 - 10/2014
2Acetylcholine (Acetylcholine Chloride)FDA Link
01/2019 - 10/2014
2Opioid Analgesics (Opioids)IBA
12/2018 - 01/2007
2NicotineFDA Link
01/2016 - 10/2014
1Cyclic PeptidesIBA
10/2021
1Transient Receptor Potential ChannelsIBA
02/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2020
1AntioxidantsIBA
08/2020
1PolyphenolsIBA
08/2020
1ResveratrolIBA
08/2020
1Angiotensin IIIBA
08/2020
1Neuroprotective AgentsIBA
01/2019
1Okadaic AcidIBA
01/2019
1Freund's AdjuvantIBA
01/2019
1Narcotics (Narcotic Analgesics)IBA
12/2018
1EnzymesIBA
01/2018
1Heme (Haem)IBA
01/2018
1Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA
01/2018
1Ciclopirox (Loprox)FDA LinkGeneric
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2017
1LigandsIBA
01/2017
1Cysteine (L-Cysteine)FDA Link
05/2013
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
05/2013
1Endothelins (Endothelin)IBA
05/2013
1Growth InhibitorsIBA
10/2011
1anthranilic acid (anthranilate)IBA
01/2007
1pyrimidineIBA
01/2007

Therapy/Procedure

2Therapeutics
12/2018 - 10/2017
1Pain Management
12/2018